Skip to main content
SpringerLink
Log in

Treatment Strategies for Women With Stable Angina

  • Chapter
Coronary Disease in Women

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 103 Accesses

Abstract

Recent evidence suggests that cardiovascular disease (CVD) mortality has been reduced 35–50% owing, in large part, to significant improvements in the management of coronary artery disease (CAD). However, CAD remains the single most important cause of morbidity and mortality in most Westernized countries for both women and men alike. Generally, the prevalence of coronary disease increases by age and varies by gender. The age-adjusted death rate per 100,000 for major CVDs in 1999 was 414.8 for men and 300.3 for women (1). However, for patients with CAD, the case fatality rate for CVD is higher for women than men (2). Since 1984, 50,000 more women on average have died each year than men.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993; 88: 2987–3007.

    Article  PubMed  CAS  Google Scholar 

  2. Anonymous. AHA medical/scientific statement. 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Circulation 1994; 90: 644–465.

    Google Scholar 

  3. Penque S, Halm M, Smith M, et al. Women and coronary disease: relationship between descriptors of signs and symptoms and diagnostic and treatment course. Am J Crit Care 1998; 7: 175–82.

    PubMed  CAS  Google Scholar 

  4. Lerner DJ, Kennel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383–390.

    Article  PubMed  CAS  Google Scholar 

  5. Wenger NK. Clinical characteristics of coronary heart disease in women: emphasis on gender differences. Cardiovasc Res 2002; 53: 558–567.

    Article  PubMed  CAS  Google Scholar 

  6. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 Guideline Update for the Management of Patients with Chronic Stable Angina: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina), 2002.

    Google Scholar 

  7. Milner KA, Funk M, Richards S. Gender differences in symptom presentation associated with coronary artery disease. Am J Cardiol 1999; 84: 396–399.

    Article  PubMed  CAS  Google Scholar 

  8. Merz CN, Kelsey SF, Pepine CJ, et al. The Women’s Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 1999; 33: 1453–1461.

    Article  PubMed  CAS  Google Scholar 

  9. Vaccarino V, Krumholz HM, Yarzebski J, et al. Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med 2001; 134: 173–181.

    PubMed  CAS  Google Scholar 

  10. Vaccarino V, Parsons L, Every NR. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med; 1999; 341: 217–225.

    Article  PubMed  CAS  Google Scholar 

  11. Taillefer R, DePuey EG, et al. Comparative diagnostic accuracy of TI-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29: 69–77.

    Article  PubMed  CAS  Google Scholar 

  12. Garg PP, Landrum MB, Normand SL, et al. Understanding individual and small area variation in the underuse of coronary angiography following acute myocardial infarction. Med Care 2002; 40: 614–626.

    Article  PubMed  Google Scholar 

  13. Bell MR, Berger PB, Holmes DR Jr, et al. Referral for coronary artery revascularization procedures after diagnostic coronary angiography: evidence for gender bias? J Am Coll Cardiol 1995; 25: 1650–1655.

    Article  PubMed  CAS  Google Scholar 

  14. Smith SC, Blair S, Bonow R, et al. AHA/ACC consensus statement on preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. Circulation 2001; 104: 1577–1579.

    Article  PubMed  Google Scholar 

  15. Adult Treatment Panel III. Executive summary of the third report of National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 2001; 285: 2486–2497.

    Google Scholar 

  16. Smith SC, Blair SN, Criqui MH, et al. Preventing heart attack and death in patients with coronary disease. Circulation 1995; 92: 2–4.

    Article  PubMed  Google Scholar 

  17. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. November, 1997. NIH Publication 98–4080.

    Google Scholar 

  18. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557–1565.

    Article  PubMed  CAS  Google Scholar 

  19. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease 1. Treatments following myocardial infarction. JAMA 1988; 260: 2088–2093.

    Article  PubMed  CAS  Google Scholar 

  20. Beta Blocker Heart Attack Trial Research Group. A randomized trial of propanolol in patients with acute myocardial infarction. JAMA 1982; 247: 1707–1714.

    Article  Google Scholar 

  21. Pfeiffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327: 669–677.

    Article  Google Scholar 

  22. The SOLVD investigators. Effect of angiotensin converting enzyme inhibitor enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293–302.

    Article  Google Scholar 

  23. Brown BG, Zhao X-Q, Sacco DE, et al. Lipid lowering and plaque regression; new insights into prevention of plaque disruption and clinical events in coronary disease Circulation 1993; 87: 1781–1791.

    CAS  Google Scholar 

  24. Blankenhom DH, Azen SP, Dramsch D, et al. Coronary angiographic changes with lovastatin therapy: The Monitored Atherosclerosis Regression Study (MARS). Ann Int Med 1993; 119: 969–976.

    Google Scholar 

  25. Waters D, Higginson L, Gladstone P, et al. Effect of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: the Canadian Coronary Atherosclerosis Intervention Trial. Circulation 1994; 89: 959–968.

    Article  PubMed  CAS  Google Scholar 

  26. Waters D, Craven TE, Lesperance J. Prognostic significance of progression of coronary atherosclerosis. Circulation 1993; 87: 1067–1075.

    Article  PubMed  CAS  Google Scholar 

  27. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389.

    Google Scholar 

  28. Mosca L, Grundy SM, Judelson D, et al. Guide to Preventive Cardiology for Women: AHA/ACC Scientific Statement: Consensus Panel Statement. Circulation 1999; 99: 2480–2484.

    Article  PubMed  CAS  Google Scholar 

  29. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol 1988(4 Suppl A):5A–10A.

    Google Scholar 

  30. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360: 7–22.

    Article  Google Scholar 

  31. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999; 282: 2340–2346.

    Article  PubMed  CAS  Google Scholar 

  32. Barrett-Connor E, Stuenkel CA. Questions of life and death in old age. JAMA 1998; 279: 622–623.

    Article  PubMed  CAS  Google Scholar 

  33. Geiss LS, in National Diabetes Data Group (U.S.). Diabetes in America, 2nd ed. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: 1995, pp. 233–257.

    Google Scholar 

  34. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 1997; 20 (Suppl 1); S5–S13.

    Google Scholar 

  35. DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial. N Engl J Med 1993; 329: 977–986.

    Article  Google Scholar 

  36. Shaw RE, Anderson HV, Brindis RG, et al. Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998–2000. J Am Coll Cardiol 2002; 39: 1104–1112.

    Article  PubMed  Google Scholar 

  37. Shaw LJ, Heller GV, Travin MI, et al. Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group. J Nucl Cardiol 1999; 6: 559–569.

    Article  PubMed  CAS  Google Scholar 

  38. Sawada SG, Lewis SJ, Foltz J, et al. Usefulness of rest and low-dose dobutamine wall motion scores in predicting survival and benefit from revascularization in patients with ischemic cardiomyopathy. Am J Cardiol 2002; 89: 811–816.

    Article  PubMed  Google Scholar 

  39. Ahmed JM, Dangas G, Lansky AJ, et al. Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting. Am J Cardiol 2001; 87: 401–405.

    Article  PubMed  CAS  Google Scholar 

  40. Cho L, Marso SP, Bhatt DL, Topol EJ. Optimizing percutaneous coronary revascularization in diabetic women: analysis from the EPISTENT trial. Journal of Womens Health Gender-Based Med 2000; 9: 741–746.

    Article  CAS  Google Scholar 

  41. Mehilli J, Kastrati A, Dirschinger J, et al. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA 2000; 284: 1799–1805.

    Article  PubMed  CAS  Google Scholar 

  42. Pepine CJ, Handberg EM. The vascular biology of hypertension and atherosclerosis and intervention with calcium antagonists and angiotensin-converting enzyme inhibitors. Clin Cardiol 2001;24(11 Suppl): V 1-V 5.

    Google Scholar 

  43. van Domburg RT, Foley DP, de Feyter PJ, et al. Long-term clinical outcome after balloon angioplasty: identification of a population at low risk of recurrent events during 17 years of follow-up. Eur Heart J 2001; 22: 934–941.

    Article  PubMed  Google Scholar 

  44. Watanabe CT, Maynard C, Ritchie JL. Comparison of short-term outcomes following coronary artery stenting in men versus women. Am J Cardiol 2001; 88: 848–852.

    Article  PubMed  CAS  Google Scholar 

  45. Herlitz J, Wiklund I, Sjorland H, et al. Relief of symptoms and improvement of health related quality of life five years after coronary artery bypass in women and men. Clin Cardiol 2001; 24: 385–392.

    Article  PubMed  CAS  Google Scholar 

  46. Williams MR, Choudri AF, Morales DL, et al. Gender differences in patients undergoing coronary bypass surgery, from a mandatory statewide database. J Gend Specif Med 2000; 3: 41–48.

    PubMed  CAS  Google Scholar 

  47. Hartz RS, Rao AV, Plomondon ME, et al. Effects of race, with or without gender, on operative mortality after coronary artery bypass grafting: a study using The Society of Thoracic Surgeons National Database. Ann Thorac Surg 2001; 71: 512–520.

    Article  PubMed  CAS  Google Scholar 

  48. Brandrup-Wognsen G, Berggren H, Hartford M, et al. Female sex is associated with increased mortality and morbidity early, but not late, after coronary bypass grafting. Eur Heart J 1996; 17: 1426–1431.

    Article  PubMed  CAS  Google Scholar 

  49. Capdeville M, Chamogeogarkis T, Lee JH. Effect of gender on outcomes of beating heart operations. Ann Thorac Surg 2001; 72: S1022–S1025.

    Article  PubMed  CAS  Google Scholar 

  50. Capdeville M, Lee JH, Taylor AL. Effect of gender on fast-track recovery after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2001; 15: 146–151.

    Article  PubMed  CAS  Google Scholar 

  51. Ott RA, Gutfinger DE, Alimadadian H, et al. Conventional coronary artery bypass grafting: why women take longer to recover. J Cardiovasc Surg (Torino) 2001; 42: 311–315.

    CAS  Google Scholar 

  52. Simchen E, Naveh I, Zitser-Gurevich Y, et al. Is participation in cardiac rehabilatation programs associated with better quality of life and return to work after coronary bypass operations? The Israeli CABG Study. Isr Med Assoc J 2001; 3: 399–403.

    PubMed  CAS  Google Scholar 

  53. Shaw LJ, Tarkington L, Callister J, et al. The HCA National Disease Management Program for coronary disease detection and treatment in women. Am J Manag Care 2001;7 Spec No:SP25–SP30.

    Google Scholar 

  54. Stafford RS. Aspirin use is low among United States outpatients with coronary artery disease. Circulation 2000; 101: 1097–1101.

    Article  PubMed  CAS  Google Scholar 

  55. Shaw LJ, Miller DD, Romeis JC, et al. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994; 120: 559–566.

    PubMed  CAS  Google Scholar 

  56. Bowling A, Bond M, McKee D, et al. Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications. Heart 2001; 85: 680–686.

    Article  PubMed  CAS  Google Scholar 

  57. Battleman DS, Callahan M. Gender differences in utilization of exercise treadmill testing: a claims based analysis. J Healthc Qual 2001; 23: 38–41.

    Article  PubMed  CAS  Google Scholar 

  58. Watson RE, Stein AD, Dwamena FC, et al. Do race and gender influence the use of invasive procedures? J Gen Intern Med 2001; 16: 227–234.

    Article  PubMed  CAS  Google Scholar 

  59. Lagerqvist B, Safstrom K, Stahle E, et al. FRISC II Study Group Investigators. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? J Am Coll Cardiol 2001; 38: 41–48.

    Article  PubMed  CAS  Google Scholar 

  60. Bedinghaus J, Leshan L, Diehr S. Coronary artery disease prevention: what’s different for women? Am Fam Physician 2001; 63: 1290–1292.

    Google Scholar 

  61. Welty FK. Cardiovascular disease and dyslipidemia in women. Arch Intern Med 2001; 161: 514–522.

    Article  PubMed  CAS  Google Scholar 

  62. Keller KB, Lemberg L. Gender differences in acute coronary events. Am J Crit Care 2000; 9: 207–209.

    PubMed  CAS  Google Scholar 

  63. Miettinen T, Pyorala K, Olsson A, et al. Cholesterol lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 1997; 96: 4211–4218.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Paul R. Casperson PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leslee J. Shaw PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert A. O’Rourke MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Outcomes Research, American Cardiovascular Research Institute, Atlanta, GA, USA

    Leslee J. Shaw PhD

  2. Division of Cardiology, University of California School of Medicine, San Francisco, CA, USA

    Rita F. Redberg MD, FACC

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Casperson, P.R., Shaw, L.J., O’Rourke, R.A. (2004). Treatment Strategies for Women With Stable Angina. In: Shaw, L.J., Redberg, R.F. (eds) Coronary Disease in Women. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-645-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-645-4_14

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-275-9

  • Online ISBN: 978-1-59259-645-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation